Express Pharma

facebook
twitter
google_plus
Email

Browsing tag

Initial Public Offering

Biocon top line grows 15 per cent in Q4 FY15

Posts pagination

Previous Page 1 of 2 Page 2 of 2

Home
- Drug approvals
- Nutraceuticals
- Cosmeceuticals
- Pharma IT
- Policies
- Technology
- Logistics
- HR
- Biotech
- Startup Corner
- AYUSH
- More
Cover Story
Features
Specials
Guest Blogs
Interviews
Editor’s note
Events
- Upcoming Events
- Event Listings
Videos
Downloads
EP Dialogues
- Episode 1
- Episode 2

View Desktop Version